MeSH term
Frequency | Condition_Probility | ABO Blood-Group System | 2 | 3.0 |
Humans | 53 | 0.0 |
Lewis Blood-Group System | 3 | 25.0 |
*Polymorphism, Genetic | 9 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 10 | 0.0 |
China | 4 | 0.0 |
DNA Mutational Analysis | 2 | 0.0 |
European Continental Ancestry Group/genetics | 3 | 0.0 |
*Evolution, Molecular | 4 | 0.0 |
Fucosyltransferases/*genetics | 23 | 45.0 |
Indonesia | 2 | 8.0 |
Japan | 3 | 0.0 |
Lewis Blood-Group System/*genetics | 5 | 41.0 |
Phylogeny | 4 | 0.0 |
Research Support, Non-U.S. Gov't | 46 | 0.0 |
Taiwan | 4 | 2.0 |
Alleles | 18 | 0.0 |
Haplotypes | 3 | 0.0 |
Polymerase Chain Reaction | 11 | 0.0 |
Sequence Analysis, DNA | 7 | 0.0 |
Animals | 22 | 0.0 |
Female | 13 | 0.0 |
Genotype | 9 | 0.0 |
Homozygote | 2 | 0.0 |
Immunohistochemistry | 3 | 0.0 |
Lectins/metabolism | 2 | 2.0 |
Male | 10 | 0.0 |
Mice | 5 | 0.0 |
Models, Genetic | 3 | 0.0 |
Mutation | 8 | 0.0 |
Open Reading Frames | 4 | 0.0 |
Phenotype | 15 | 0.0 |
Glycosylation | 2 | 0.0 |
Comparative Study | 9 | 0.0 |
Gene Frequency | 5 | 0.0 |
Polymorphism, Genetic | 4 | 0.0 |
Polymorphism, Restriction Fragment Length | 8 | 0.0 |
Pseudogenes | 2 | 1.0 |
Sequence Homology, Nucleic Acid | 6 | 0.0 |
*Vesicular Transport Proteins | 2 | 1.0 |
Base Sequence | 17 | 0.0 |
COS Cells | 11 | 0.0 |
Chromosome Mapping | 5 | 0.0 |
Cloning, Molecular | 9 | 0.0 |
In Situ Hybridization | 3 | 0.0 |
Molecular Sequence Data | 21 | 0.0 |
Transfection | 9 | 0.0 |
English Abstract | 2 | 0.0 |
Amino Acid Sequence | 5 | 0.0 |
CHO Cells | 2 | 0.0 |
Hamsters | 3 | 0.0 |
Kinetics | 4 | 0.0 |
Sequence Homology, Amino Acid | 3 | 0.0 |
Tumor Cells, Cultured | 2 | 0.0 |
ABO Blood-Group System/genetics | 2 | 4.0 |
*Alleles | 3 | 0.0 |
DNA Primers | 3 | 0.0 |
ABO Blood-Group System/*genetics | 12 | 25.0 |
DNA | 2 | 0.0 |
Fucosyltransferases/*genetics/metabolism | 3 | 30.0 |
Swine | 3 | 0.0 |
Adult | 2 | 0.0 |
Middle Aged | 2 | 0.0 |
Thailand/ethnology | 2 | 22.0 |
Exons | 3 | 0.0 |
*Gene Deletion | 2 | 0.0 |
Introns | 3 | 0.0 |
Linkage (Genetics) | 2 | 0.0 |
Alu Elements/*genetics | 2 | 6.0 |
Cell Line | 2 | 0.0 |
*Mutation | 6 | 0.0 |
Evolution, Molecular | 2 | 0.0 |
Blood Grouping and Crossmatching | 3 | 4.0 |
Fucosyltransferases/genetics | 3 | 30.0 |
Point Mutation | 4 | 0.0 |
Genetic Predisposition to Disease | 3 | 0.0 |
Restriction Mapping | 4 | 0.0 |
Fucosyltransferases/genetics/*metabolism | 2 | 28.0 |
Asian Continental Ancestry Group/*genetics | 2 | 0.0 |
Fucosyltransferases/*genetics/*metabolism | 2 | 66.0 |
Pedigree | 4 | 0.0 |
Saliva/immunology | 3 | 11.0 |
Erythrocytes/immunology | 2 | 0.0 |
*Chromosome Mapping | 2 | 0.0 |
RNA, Messenger/genetics/metabolism | 2 | 0.0 |
Cosmids | 2 | 0.0 |
Genetic Markers | 4 | 0.0 |
In Situ Hybridization, Fluorescence | 2 | 0.0 |
*Chromosomes, Human, Pair 19 | 2 | 0.0 |
Hybrid Cells | 2 | 0.0 |
Blood Group Antigens/*genetics | 4 | 3.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 3 | 0.0 |
Carbohydrate Sequence | 3 | 0.0 |
Lod Score | 2 | 0.0 |
Fucosyltransferases/deficiency/*genetics | 2 | 100.0 |